Pharmagreen Biotech Inc. reported earnings results for the full year ended September 30, 2022. For the full year, the company reported net loss was USD 0.875478 million compared to USD 4.53 million a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0009 USD | +12.50% | +28.57% | +50.00% |
1st Jan change | Capi. | |
---|---|---|
+50.00% | 531K | |
+24.98% | 46.71B | |
+48.83% | 41.8B | |
-1.18% | 41.52B | |
-3.42% | 29.55B | |
+10.48% | 25.78B | |
-21.06% | 19.26B | |
+1.58% | 12.14B | |
-3.41% | 12.08B | |
+27.24% | 11.98B |
- Stock Market
- Equities
- PHBI Stock
- News Pharmagreen Biotech Inc.
- Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2022